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Derivation of Functional Human 
Astrocytes from Cerebral Organoids
Rômulo Sperduto Dezonne1, Rafaela Costa Sartore1,2, Juliana Minardi Nascimento2,3, 
Verônica M. Saia-Cereda3, Luciana Ferreira Romão1,4, Soniza Vieira Alves-Leon5, 
Jorge Marcondes de Souza5, Daniel Martins-de-Souza3, Stevens Kastrup Rehen1,2 & 
Flávia Carvalho Alcantara Gomes1
Astrocytes play a critical role in the development and homeostasis of the central nervous system 
(CNS). Astrocyte dysfunction results in several neurological and degenerative diseases. However, 
a major challenge to our understanding of astrocyte physiology and pathology is the restriction of 
studies to animal models, human post-mortem brain tissues, or samples obtained from invasive 
surgical procedures. Here, we report a protocol to generate human functional astrocytes from 
cerebral organoids derived from human pluripotent stem cells. The cellular isolation of cerebral 
organoids yielded cells that were morphologically and functionally like astrocytes. Immunolabelling 
and proteomic assays revealed that human organoid-derived astrocytes express the main astrocytic 
molecular markers, including glutamate transporters, specific enzymes and cytoskeletal proteins. We 
found that organoid-derived astrocytes strongly supported neuronal survival and neurite outgrowth 
and responded to ATP through transient calcium wave elevations, which are hallmarks of astrocyte 
physiology. Additionally, these astrocytes presented similar functional pathways to those isolated from 
adult human cortex by surgical procedures. This is the first study to provide proteomic and functional 
analyses of astrocytes isolated from human cerebral organoids. The isolation of these astrocytes holds 
great potential for the investigation of developmental and evolutionary features of the human brain 
and provides a useful approach to drug screening and neurodegenerative disease modelling.
Astrocytes have been the subject of a huge paradigm shift in neurosciences during the last decades. Initially 
classified as passive and merely supporting cells, today, astrocytes are known as active components of brain devel-
opment, homeostasis and function. These features include the regulation of blood flow, blood brain barrier for-
mation and function, and synapse formation and elimination1–4. Additionally, astrocytes play a role in the control 
of neurotransmitters and potassium levels and as a source of neurotrophic and survival factors5–12.
Due to its overall role in brain function, astroglial dysfunction has been implicated in most neurological dis-
orders and neurodegenerative diseases. However, our understanding of astrocyte physiology and pathology has 
been restricted to animal models, human postmortem brain tissue and astrocytes derived from clinical invasive 
procedures. Additionally, recent observations have revealed that murine and human astrocytes differ considera-
bly not only morphologically but also functionally and at the molecular level13–16. These data highlight the need 
for the development of non-invasive experimental models for studying human brain astrocytes.
Several groups have focused on deriving astroglia from rodent and human progenitor cells (for a review, see 
Chen et al., 2015). A few caveats of the methods utilized to date include long-term culture, invasive surgical pro-
cedures for obtaining human cells, questionable cell culture purity, and the use of specific induction factors, such 
as fibroblast growth factor (FGF), leukemia-inhibiting factor (LIF), ciliary neurotrophic factor (CNTF) or bone 
morphogenetic proteins (BMPs), which not only endure the procedure but drive progenitors towards a specific 
astrocyte phenotype.
Recently, organoids derived from human stem cells such as human embryonic stem cells (ESCs), tissue-specific 
progenitor cells or induced pluripotent stem cells (iPSs) have emerged as an appropriate model for the study of 
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human development, since they spontaneously recapitulate the morphogenic features and functions of living 
organs in vitro17,18.
Cerebral organoid generation is based on the intrinsic capacity of human pluripotent stem cells to differentiate 
towards neural lineages without an external supply of morphogens or pharmacological inhibitors18–20. Recently, 
by using an adapted protocol from Lancaster and co-worker, we developed a new approach for the production of 
cerebral organoids in spinner flasks21. These brain organoids resemble the human cerebral cortex, as evidenced 
by the presence of radial glia progenitor cells, ventricular and subventricular zones, intermediate progenitors and 
an organized cortical plate19,20,22.
Here, we report the development of a simple and efficient protocol for generating purified functional cortical 
human astrocytes from cerebral organoids. The astrocytes were isolated from cerebral organoids derived from 
ESCs. All derived cells presented a morphology and molecular markers compatible with human cultured astro-
cytes. Moreover, functional assays attested their astrocytic phenotype, including a transient elevation of calcium 
waves in response to ATP and neurotrophic properties. Our work provides a simple and reproducible method 
that holds the potential to reveal human astrocytes behaviour in neuropsychiatric and degenerative disorders, 
address comparative evolutionary studies and might provide a suitable tool for drug screening and disease mod-
elling in vitro.
Results
Astrocyte isolation from cerebral organoids and morphological characterization. Cerebral 
organoids were derived from embryonic stem cells (BR1 and H9) as previously described19,20. After 45 days of dif-
ferentiation (Fig. 1A), they presented a well-organized structure composed of radial glia (RG) cells characterized 
by Nestin filament that spanned all organoids and BLBP (brain lipid binding protein) located around cavities that 
resemble cerebral ventricles (Fig. 1A). Cerebral organoids also presented staining for β -tubulin III in a well-or-
ganized cortical plate, and staining for the progenitor marker, Pax6, around ventricle-like structures that establish 
the ventricular and subventricular zones (Fig. 1A). At this stage, approximately 15 cerebral organoids from each 
Figure 1. Astrocyte isolation protocol. (A) Cerebral organoids were maintained for 45 days, followed by 
immunostaining for Nestin, BLBP, β -tubulin III and PAX6. Progenitor cell bodies (radial glial cells) were 
observed around a cavity resembling the ventricle and cortical plate and the progenitor zones stained with 
β -tubulin III and PAX6, respectively. (B) For astrocyte isolation, cerebral organoids were mechanically 
dissociated and cells were plated onto a laminin-coated 100-mm culture dish (Passage 0). After 4 days at passage 
0, the cells were enzymatically removed by trypsin digestion, plated in a 100-mm culture dish, and maintained 
until reaching confluency (7–9 DIV, approximately) (Passage 1). This step was successively repeated to achieve 
Passages 2, 3, and 4. All experiments described herein were conducted at Passage 4. (C) Cells were isolated 
from H9 and BR1 cerebral organoids at 1 DIV (Passage 0), 4 DIV (Passage 0), 11 DIV (Passage 2) and 32 DIV 
(Passage 4). Note that the cells present a flat, fibroblast-like appearance, which is characteristic of astrocytes 
in culture (11 and 32 DIV). Scale bars: 1000 μ m cerebral organoid light microscopy (A); 100 μ m fluorescence 
microscopy (A); 200 μ m (C, 1 and 4 DIV); 500 μ m (C, 11 and 32 DIV); 100 μ m (C, 32 DIV).
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lineage were mechanically dissociated, and the cells were plated onto a 100-mm culture dish that was previously 
coated with polyornithine and laminin to enhance neuronal progenitor adhesion; this was assigned as passage 
0 in the scheme (Fig. 1B). To enrich the pool of astrocyte progenitors, the cells were cultured in astrocyte basic 
growth medium consisting of DMEM-F12 supplemented with 10% FBS for 4 days in vitro (DIV)7,10,23,24. After 
24 hours, a heterogeneous culture was obtained that contained undissociated cells from the cerebral organoid, 
and astrocyte-like cell (Fig. 1C, 1 DIV). At 4 DIV, we observed an astrocyte-like monolayer underneath neurons 
and progenitors (Fig. 1C, 4 DIV). Subsequently, the cells were expanded through 4 consecutive passages (Fig. 1B). 
After the initial passages, the culture became homogeneous (Fig. 1C), with an astrocyte-like morphology (Fig. 1C, 
11 and 32 DIV) were obtained. After a month in culture, we performed molecular and functional characterization 
of astrocytes at passage 4, that is, 32 DIV (Fig. 1C, 32 DIV).
To morphologically define human astrocytes derived from BR1 and H9 cerebral organoids, the cells were 
analysed by light microscopy. The cells developed a flat, fibroblast-like morphology as previously described for 
astrocytes maintained in vitro. No significant morphological difference was noted between the cell lines (Fig. 1C, 
32 DIV). Similarly, the culture expansion was successful, and the growth rate was equivalent between cell lines.
Molecular characterization. We subsequently performed a molecular characterization by identifying 
astrocytic markers by immunocytochemistry and proteomic assays. To evaluate the global protein expression 
of astrocytes derived from stem cells, we performed state-of-the-art shotgun proteomics and identified 3,048 
proteins, demonstrating the overlap of 85.8% of the identified proteins (Fig. 2A) among hESC-derived astrocytes 
from BR1 and H9, as well as human adult astrocytes. In addition, the Spearman correlation analysis revealed a 
strong correlation regarding the relative protein abundances between hESC-derived astrocytes and human adult 
astrocytes (P = 0.7081, Fig. 2B). For example, we show commonly identified proteins in astrocytes, such as GFAP 
(glial fibrillary acidic protein), vimentin and ALDH1L1 (aldehyde dehydrogenase 1 family member L1), both in 
hESC-derived and adult astrocytes, with similar abundances (Fig. 2C). We also detected markers of immature 
astrocytes such as ERBB2 and galectin 3 (LGALS3) in both samples, with no significant differences.
Immunolabelling assays revealed that all human astrocytes derived from cerebral organoids from both hESC 
lineages presented most of the main astrocyte makers, including GFAP, glutamine synthetase, BLBP (brain 
lipid-binding protein), S100β , and vimentin. Additionally, differentiated astrocytes were also positive for the 
glutamate transporters, GLAST (glutamate aspartate transporter) and GLT1 (glutamate transporter 1), and for 
the NMDA (N-methyl-D-aspartate) receptor (Fig. 3). The cultures showed no reactivity towards Nestin, olig2 
(oligodendrocyte transcription factor), FOXG1 (forkhead box G1) or β -tubulin III (Table 1), attesting their com-
mitment towards the astroglial lineage.
Protein-protein interaction pathways (interactome). We identified over-represented ontological 
groups and pathways amongst proteins of BR1 and H9 astrocytes compared with human adult astrocytes. As 
shown in Fig. 4, there were no significant differences between these two groups. BR1 and H9 astrocytes pre-
sented the same major thirteen representative pathways observed in adult human astrocytes. Using the specific 
proteins found in the proteomic assay, we explored the interactome of BR1 and H9 astrocytes. We identified pro-
teins involved in pathways related to axonal guidance, such as ephrins (EFNB1) and netrins (NTN4); angiogenic 
activity, including angiopoietin-2 (ANGPT2), EFNB1 and bFGF; neurotrophic growth factors, such as bFGF; 
glutamate receptor response and intracellular calcium effectors, such as CAMK (CAMK2A and CAMK2B); the 
neuregulin response, EGFR and ERBB2; and the inflammatory-mediated response, NFk-β (NFKB1). As demon-
strated in Fig. 4, the interactome of astrocytes derived from BR1 and H9 embryonic cell lines is very similar to 
those isolated from adult human cortex.
Functional characterization. To determine whether astrocytes derived from cerebral organoids were 
biologically active, we performed two functional assays: analysis of neurotrophic support and measurement of 
calcium waves in response to ATP stimuli. Mouse and human astrocytes respond to sensory inputs, such as 
glutamate and ATP, via transient calcium waves25–28. To investigate whether human astrocytes derived from our 
protocol also respond to these extracellular cues, we performed calcium imaging assays. We treated BR1 and 
H9-derived astrocytes for 60 s with an influx of 100 μ M ATP. An efficient response to ATP was considered 20% 
above the cellular baseline. As shown in Fig. 5, all murine astrocytes responded to ATP (Fig. 5A). In BR1 (Fig. 5A) 
and H9 (Fig. 5A) astrocyte cultures, approximately 50% of the cells responded efficiently to ATP. Of note, the 
responsive cells presented a well-recognized asynchrony, which is a feature of human astrocytes25.
Astrocytes constitute the main source of neurotrophic factors during nervous system development7,10,24,29–31. 
To investigate neurotrophic properties from BR1 and H9 astrocytes, we tested whether human astrocytes promote 
neuronal survival by using a coculture model with murine embryonic cortical neurons. After 48 h, the number of 
murine β -tubulin III-positive cells was quantified. As a positive control, we used murine cortical neonatal astro-
cytes, which are known to support neuronal survival. Murine embryonic fibroblasts (MEFs) served as negative 
controls (Fig. 5B). We found that human astrocytes derived from cerebral organoids strongly sustained neuronal 
survival (Fig. 5B and C). Astrocytes derived from BR1 organoids presented an even increased supportive capacity 
compared with their murine counterparts (Fig. 5C). However, MEFs provided poor support for cortical neurons 
(Fig. 5C), indicating that neuronal survival was not due to cell contact but specifically to neuron-astrocyte sig-
nalling. Our data show that human astrocytes derived from BR1 and H9 cerebral organoids share the ability of 
murine astrocytes to promote neuronal survival in vitro.
In due course, to investigate the neurotrophic properties of soluble factors secreted by BR1 and H9 astrocytes, 
embryonic cerebral cortex progenitors were cultured for 48 hours in the presence of conditioned media obtained 
from BR1 and H9 astrocytes (BR1 or H9-ACM), or neurobasal medium alone (Fig. 5D). To evaluate the effect of 
BR1 and H9-ACM on neurite growth, neurite lengths were analysed using three parameters: either considering 
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the sum of the total neurite length per neuron (Fig. 5E), the longest neurite per neuron or the sum of all neurite 
measurements divided by the number of processes per neuron (data not shown). BR1 and H9 ACM promoted a 
100% increment in neurite outgrowth (Fig. 5E). Moreover, approximately 40% of the neuronal cells grown on BR1 
and H9-ACM developed neurites with an average size of more than 200 μ m, whereas only approximately 5% of 
the neurons plated on neurobasal (Fig. 5D Control) medium displayed these characteristics (Fig. 5F). Together, 
these results show that BR1 and H9 astrocytes are neurotrophic and induce cortical progenitor neurite outgrowth.
The data presented herein show that astrocytes derived from BR1 and H9 organoids present morphologic, 
genetic and functional properties that confirm their astrocytic identity. Together, our data show that the protocol 
described herein is useful for the large-scale isolation of functional human astrocytes from two different lines, 
BR1 and H9.
Figure 2. Proteomics profile of astrocytes derived from hESC-cerebral organoids and human adult surgical 
specimens. (A) Venn diagram comparing the number of proteins identified by shotgun mass spectrometry of 
astrocytes derived from hESC cell lines, BR1 and H9-cerebral organoids, and human adult astrocytes.  
(B) Spearman correlation between global relative protein expression of hESC-cerebral organoids-astrocytes and 
human adult astrocytes. p represents the spearman correlation coefficient. (C) Plot of selected proteins related 
to astrocytes; the comparison was normalized to the abundance of proteins from hESC-derived and human 
adult astrocytes.
www.nature.com/scientificreports/
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Figure 3. Morphological and immunostaining characterization of astrocytes derived from BR1- and H9-
cerebral organoids. Immunostaining of astrocytes (Passage 4) derived from BR1/H9-cerebral organoids for 
astroglial markers after 7 DIV. GFAP (A,B), glutamine synthetase (G.SYNT; C,D), brain lipid binding protein 
(BLBP; E,F), S100β (G,H), vimentin (I,J), glutamate transporter GLAST (K-L), glutamate transporter GLT-1 
(M,N), N-methyl-D-aspartate receptor (NMDAr; O,P). Nuclei were stained blue (DAPI). Scale bar: 50 μ m.
Classification* Markers§
BR1 
astrocyte
H9 
astrocyte
Neuronal β Tubulin III − − 
Neuronal/
Astroglial NMDA receptor + + 
Progenitor
Nestin − − 
Olig 2 − − 
Foxg1 − − 
Astroglial
Vimentin + + 
GFAP + + 
GLAST + + 
S100β + + 
BLBP + + 
GLT1 + + 
G. synthetase + + 
Table 1.  Summary of molecular markers analysed in organoids derived astrocytes by immunocytochemistry. 
*Type of neural lineage in which the specific marker is commonly found. §Specific markers identified by 
immunocytochemistry.
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Discussion
Here, we present a new protocol to isolate human astrocytes from cerebral cortical organoids. We demonstrate 
that human astrocytes derived from BR1 and H9 cerebral organoids develop a flat, fibroblast-like appearance as 
expected for cultured human astrocytes22. Our molecular portrayal, by immunolabelling and proteomic assays, 
revealed that cells derived from both lineages present most characteristic astrocyte markers. Functional experi-
ments validated that both BR1 and H9 astrocytes are supportive of cortical murine neurons and induce neurite 
outgrowth. Furthermore, at least 50% of BR1 and H9 astrocytes also response to an ATP stimulus with asyn-
chronous calcium waves25, a hallmark of the biological function of astrocytes. We suggest that our method might 
provide a useful new tool for drug screening and neurodegenerative disease modelling.
Other groups have succeeded in establishing standard protocols for the generation of astrocytes from ESC and 
iPS by supplementation with different growth factors such as cardiotrophin 1 (CT-1), LIF or other gliogenic mole-
cules11,32–35. The methods used to date present several constraints including long-term culture and a questionable 
culture purity that could eventually drive the cells towards a specific phenotype due to the use of differentiation 
factors and the high cost of the procedure.
Here, we developed a time-saving protocol of astrocyte differentiation and isolation based on FBS medium 
supplementation, followed by subsequent passaging of progenitor cells isolated from cortical organoids. Each 
100-mm dish was divided into five or more dishes during these passages, which allowed greater expansion of 
isolated cells. Additionally, previous works only examined the morphology of GFAP + cells after cerebral orga-
noid dissociation, with maintenance in defined serum-free medium22. This is the first description of cerebral 
Figure 4. Network interactive organization of proteins from astrocytes. (A) Functional enrichment of 
canonical pathway proteins in astrocytes derived from hESC-cerebral organoids and human adult cortex.  
(B) Interactive network representation of the molecular relationship between proteins found in astrocytes from 
the dataset based on String (string-db.org/).
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organoids as a useful resource for the isolation of functional astrocytes, which not only respond to ATP signalling 
through calcium waves but sustain neuronal survival and induce neurite outgrowth of cortical murine embryonic 
neurons.
BR1 and H9 astrocytes developed a flat, fibroblast-like appearance, as expected for astrocytes cultured in the 
presence of FBS22. Likewise, cells express some of the major astrocyte markers, such as GFAP, S100β , glutamine 
synthetase, and connexin 4336–39, indicating a high specificity towards astroglial commitment. Additionally, 
non-astrocyte markers, including the progenitor markers Nestin and FOXG1, markers of progenitor cells (radial 
glia)40–43, were not identified in these cells, thus indicating a differentiation/maturation process. Additional char-
acteristic markers of cultured astrocytes were present, such as vimentin, BLBP and GLAST40,44–47. These later 
findings might also indicate the reactivity that was previously reported to be induced by FBS22. It is well-known 
that reactive astrocytes develop some characteristics of immature cells, such as the expression of vimentin and 
BLBP48–56. In addition, BR1 and H9 astrocytes stained for rNMDA and GLT1, which are specific for mature 
astrocytes57,58.
In conclusion, we have identified several astrocytic proteins in astrocyte derived from organoids, including 
metabolic enzymes, cytoskeleton proteins, calcium binding protein, neurotransmitters receptors. It is important 
to note that although cells express different intensity of staining, they all stain for all astrocytic markers (double 
and triple staining), attesting their astrocytic phenotype.
The heterogeneity of astrocytes phenotypes obtained here is an important issue and little is known about 
the mechanisms that direct astrocyte diversity and whether heterogeneity is represented in vitro. Besides, there 
are no well-established regional markers of astrocytes that could distinguish subpopulations of astrocytes either 
in vitro or in vivo. Recently, our group have identified different profile of synaptogenic molecules produced by 
Figure 5. Functional characterization of BR1 and H9-cerebral organoids derived astrocytes. (A) 
Intracellular calcium levels [Ca2+] were measured after ATP stimulation in three different astrocyte monolayers: 
neonatal secondary cortical murine astrocytes, H9-derived astrocytes, and BR1-derived astrocytes. The graphs 
show the internal variations in [Ca2+]i over time (seconds). The astrocyte cultures were loaded for 40 min 
with Fura-2/AM and pluronic acid F-127 in Krebs solution. The cells were continuously perfused with Krebs 
solution and stimulated with 100 μ M ATP (at 5 s) for 60 s. (B) Embryonic murine cortical neurons were cultured 
over four different astrocyte monolayers: murine embryonic fibroblasts (MEFs); neonatal secondary cortical 
murine astrocytes (M. Ast); BR1 astrocytes and H9 astrocytes. After 48 h of coculture, the cells were stained 
for β -tubulin III, and the number of neurons was quantified (C). (D) Embryonic murine cortical neurons were 
cultured in the presence of different conditioned media, and the neurite length was measured after 48 h: BR1 
astrocyte conditioned medium, H9 astrocyte conditioned medium and neurobasal medium (Control). At 
least 100 neurons were randomly chosen and analysed in each condition; (E) neurite length; (F) neurite length 
distribution in each population. Nuclei stained in blue (DAPI). Scale bars: 50 μ m (B) and 100 μ m (D), *P < 0.05; 
****P < 0.001; N = 3.
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astrocytes from different regions59. The presence of forebrain marker, FOXG1 in the brain organoids, suggest that 
cells derived from those organoids might present forebrain characteristics60,61.The astrocytes derived here are 
probably generated by radial glia cells present in a defined progenitor zone staining positive for Nestin and BLBP.
Here, we also evaluated the global protein expression of BR1- and H9-derived astrocytes by performing 
state-of-the-art shotgun proteomics, and we identified 2,616 common proteins compared with human adult iso-
lated astrocytes. This revealed an 85.8% overlap of identified proteins. In addition, we found a strong correla-
tion regarding the relative abundances of those proteins with human adult astrocytes, as shown by Spearman 
correlation. Altogether, these data strongly support the similarity between astrocytes derived from BR1 and H9 
ESCs to those isolated from adult human cortex. The three astrocytic markers GFAP, ALDH1L1 (aldehyde dehy-
drogenase 1 family member L1) and GJA1 (gap junction protein alpha 1), previously described by Zhang and 
co-workers25, showed similar levels in ESC-derived astrocytes and those isolated from human adults. Both sam-
ples also presented equal levels of markers expressed by immature astrocytes like vimentin51, ERBB262–64 and 
galectin 3 (LGALS3)25. Together, our data show that astrocytes derived from human organoids present combined 
features of immature and mature human astrocytes.
Non-invasive isolation of astrocytes from humans might represent a powerful tool for modelling neurological 
diseases. To ensure that our protocol provides an efficient method for the derivation of human astrocytes from 
individuals, we have also applied the above-described protocol to cerebral organoids derived from iPS obtained 
from fibroblasts65(data not shown). In early passage 2, astrocytes obtained from iPS-organoids previously express-
ing astroglial markers confirmed that our protocol could successfully induce astrocyte commitment and isolation 
from organoids derived either from human embryonic stem cells or induced pluripotent stem cells (data not 
shown).
A hallmark of astroglial physiology is the ability to respond to ATP or glutamate by evoking calcium waves 
to control synaptic and neural circuit formation and function2,16,25,66–69. We demonstrated herein that both BR1 
and H9 astrocytes respond to 100 μ M ATP influx with calcium waves. However, 50% of the cells in each culture 
were capable of eliciting this proper answer, in contrast to the murine samples (100% response). The observed 
asynchronous pattern was expected for human astrocytes, as previously described by Zhang and coworkers25. 
Such differences in calcium wave oscillation might represent one of the differences between astrocytes from dis-
tinct species and might underlie the biological functional complexity of human astrocytes in comparison to their 
rodent counterparts13–15. As previously described all cells express GFAP and several other astrocytic markers 
(100%), although with different intensity. Based in these observations, we suggest that cells derived from orga-
noids are all astrocytes. However, differences in astrocyte markers staining and calcium waves might be attributed 
either to different subpopulation of astrocytes or to different developmental stages of these cells. Different levels 
of GFAP expression have been reported either for different brain regions and for subpopulations in the same 
region59. The presence of astrocytes in different maturation stages is also supported by the fact that astrocytes 
maintained for 30 days in vitro respond more robustly to ATP, in cell number, (70% BR1 and 63,8% H9) compared 
with those from 7 days (50%), suggesting that those cells mature in vitro.
In the CNS, astrocytes are the major source of trophic factors and the extracellular matrix that guides neuronal 
morphogenesis10,11,30,70–72. To confirm that the BR1 and H9-derived astrocytes were biologically functional cells, 
we performed two neurotrophic support assays: neuronal support and axonal growth assays. BR and H9 astrocyte 
monolayers provided a good substrate for neuronal survival. However, in BR1 and H9 human astrocyte monolay-
ers, murine neurons were preferentially arranged into islands, probably due to some specificity between species. 
We also showed that conditioned media from BR1 and H9 derived astrocytes increased the neurite outgrowth of 
cortical murine embryonic neurons.
Astrocyte conditioned medium contains soluble factors with neurotrophic properties. We identified 
over-represented ontological groups and pathways amongst proteins of BR1 and H9 astrocytes compared with 
human adult astrocytes. Using proteomic and bioinformatic assays, we identified some proteins related to axonal 
guidance like ephrins and netrins73, as well as neurotrophic growth factors such as bFGF74. A complete analysis 
of the secretome profile would provide further information about the growth factors that are secreted by human 
astrocytes. The interactome might shed light into the biological function of astrocytes since the proteins listed 
are representative of enriched pathways and interactions between them. Among these pathways, we also detected 
potentially functional pathways represented by the intracellular calcium effector, CAMK75; the inflammatory 
mediated response marker, NFk-β 76; and molecules related to angiogenic activity, such as angiopoietin-277, 
EphrinB1 and bFGF78. The proteins found on these well-known pathways do not differ compared with adult 
surgery isolated astrocytes, validating the similarities between them.
Our work provides a useful tool to study human astrocyte physiology independently of conventional animal 
models. This is especially important because recent observations revealed that murine and human astrocytes 
differ morphologically and functionally at the molecular level13–16. In contrast to post-mortem brain tissue or 
astrocytes obtained by surgery, the method described herein offers a simple, non-invasive procedure to access 
human astrocytes. This is the first study to provide proteomic and functional analyses of astrocytes isolated from 
cerebral organoids. The protocol described herein might represent a useful model for studying the roles of human 
astrocytes in brain function and their implications for neuropsychiatric and degenerative disorders.
Materials and Methods
Ethical approval. All animal protocols were approved by the Animal Research Committee of the Federal 
University of Rio de Janeiro (CEUA01200.001568/2013-87). Procedures were all in accordance with the ‘Guide 
for the Care and Use of Laboratory Animals’. Efforts were made to minimize animal suffering and to reduce the 
number of animals used. Human adult astrocytes were isolated from patients selected for surgical treatment of 
temporal lobe epilepsy associated with hippocampus sclerosis at the Hospital Universitário Clementino Fraga 
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Filho All patients provided written consent to participate in the study, and the procedures were in agreement with 
the Brazilian Ministry of Health Ethics Committee under the protocol CONEP2340.
Murine astrocyte secondary cultures. Astrocyte primary cultures were prepared from cerebral cortex 
derived from new-born Swiss mice as previously described79. Briefly, after decapitation, mouse brain structures 
were removed, and the meninges were carefully stripped off. Tissues were washed in phosphate-buffered saline 
(PBS) containing 0.6% glucose (Merck, Darmstadt, Hessen, DE), and cortical structures were dissociated into 
single cells in a medium consisting of Dulbecco’s Modified Eagle’s Medium supplemented with the nutrient mix-
ture F-12 (DMEM/F-12, Invitrogen Life Technologies, Carlsbad, California, USA) and enriched with glucose 
(3.3 × 10−2 M), glutamine (2 × 10−3 M) and sodium bicarbonate (0.3 × 10−2 M). Dissociated cells were plated 
onto plastic culture flasks or glass coverslips (24-well plates, Techno Plastic Products, Trasadingen, CH) that 
were previously coated with polyornithine (1.5 μ g/mL, molecular weight 41,000; Sigma Chemical Co., St Louis, 
Missouri, USA) in DMEM/F12 supplemented with 10% foetal bovine serum (FBS) (Invitrogen). The cultures 
were incubated at 37 °C in a humidified 5% CO2, 95% air chamber. After 24 h, the cell cultures were washed, 
and the medium was replaced with DMEM/F-12 supplemented with 10% FBS. The medium was changed every 
second day until the cells reached confluence, at which time the astrocyte monolayers were enzymatically disso-
ciated with trypsin (Sigma) for 5 min at 37 °C in a humidified 5% CO2, 95% air chamber. Trypsin was inhibited by 
addition of DMEM-F12 supplemented with 10% FBS and centrifuged (~200 g) for 5 min. The cells (10 × 105) were 
plated on glass coverslips that had been previously coated with polyornithine (1.5 μ g/mL; Sigma), and the cultures 
were incubated at 37 °C in a humidified 5% CO2, 95% air chamber in DMEM/F-12 supplemented with 10% FBS. 
The medium was changed every second day until the cells reached confluence.
Human adult astrocyte isolation and culture. Adult primary human astrocytes were isolated from 
surgically resected anterior temporal lobe tissue and from patients who were selected for surgical treatment of 
temporal lobe epilepsy associated with hippocampus sclerosis as previously described3. The selected patients 
were evaluated by video-electroencephalography monitoring with a 132-channel Nihon-Kohden®apparatus, and 
the ictal onset zone was concordant with neuroimaging and semiology data. The pathological tissue targeted in 
surgery for these cases is the gliotic hippocampus, and the anterior temporal lobe resection is used merely as a 
surgical pathway to the diseased area. As described previously, only healthy cortical tissue was used to produce 
astrocyte cultures. Experimental protocols were performed as described previously37. Briefly, the tissues were 
washed in DMEM-F12 (Invitrogen), mechanically dissociated, chopped into small (<2 mm3) pieces with a sterile 
scalpel, and incubated in 10 mL of 0.25% trypsin solution at 37 °C for 10 min. After centrifugation for 10 min, the 
cell pellet was suspended in DMEM/F-12 growth medium supplemented with 10% FBS (Invitrogen) and plated 
on tissue culture plates in a humidified 5% CO2, 95% air atmosphere at 37 °C for 2 h to allow the microglial cell 
to adhere. The nonadherent astrocytes were transferred into other culture plates that had been coated with poly-
ornithine (1.5 μ g/mL; Sigma). Adherent astrocytes were allowed to grow by replacing the medium once a week. 
New passages of cells were generated by harvesting confluent astrocyte cultures using trypsin (Sigma). Human 
astrocytes collected from up to the third passage were used in this study.
Cerebral organoid production. Human embryonic stem cells (hESC), BR-180 and H981 cell lines were 
cultured in mTeSR1 medium (Stemcell Technologies, Vancouver, Canada) on a Matrigel (BD Biosciences)-coated 
surface. The colonies were manually passaged every seven days and maintained at 37 °C in humidified air with 5% 
CO2. The differentiation into cerebral organoids was performed as previously described21. Briefly, 250,000 cells/mL 
were inoculated into a spinner flask containing mTeSR1 medium supplemented with 10 μ M Y-27632 
(Rho-associated protein kinase inhibitor, iRock) (Merck) under uninterrupted exposure to 40 rpm. After 24 h, the 
medium was replaced with embryoid body media. By day 6, embryoid bodies were fed neural induction medium 
containing N2 supplement and heparin. On day 11, cellular aggregates were covered in Matrigel and cultured in 
differentiation medium containing Neurobasal (Invitrogen), N2 (Invitrogen), B27 minus vitamin A (Invitrogen), 
and insulin. After 4 days, the medium was changed using the same formulation, except with the replacement of 
B27 with vitamin A (Invitrogen). The medium was changed every week. The cerebral organoids were allowed to 
grow for 45 days.
Human astrocyte derivation from cerebral organoids. Cerebral organoids that had been differenti-
ated for 45 days (derived from BR1 and H9 cell lines) were used for astrocyte isolation. Initially, approximately 15 
cerebral organoids were mechanically dissociated and plated (~6 × 106 cells/dish) in three 100-mm culture dishes 
that had been previously coated with polyornithine (1.5 μ g/mL, Sigma) and laminin (5 μ g/mL in PBS for 4 h, 
Sigma). They were then maintained in this condition until they reached confluency after approximately four days. 
The cells were maintained in DMEM/F12 (Invitrogen) supplemented with 10% FBS (Invitrogen). After achieving 
confluency (passage 0), the cell monolayers were enzymatically dissociated with trypsin (Sigma) for 5 min at 
37 °C in a humidified 5% CO2, 95% air chamber. Trypsin was inhibited by addition of DMEM-F12 supplemented 
with 10% FBS followed by centrifugation (~200 × g) for 5 min. The cells (5 × 105) were plated on a 100-mm 
culture dish that had been previously coated with polyornithine (1.5 μ g/mL; Sigma) and grown in DMEM/F-12 
supplemented with 10% FBS medium for approximately 7–9 days at 37 °C in a humidified 5% CO2, 95% air cham-
ber (passage 1). The medium was changed every second day until the culture reached confluency. The step was 
repeated successively to acquire passages 2, 3, 4 and 5. For each passage, a cell sample was frozen in 10% dimethyl 
sulfoxide (DMSO, Sigma) for future use and characterization. Characterizations were performed using passage 4 
astrocytes. For functional and immunolabelling assays, astrocytes were maintained (approximately 2 × 104 cells/
well) on glass coverslips (24-well plates, Techno Plastic Products, Trasadingen, CH) that had been previously 
coated with polyornithine (1.5 μ g/mL, Sigma) until reaching confluency. Organoids were derived from different 
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series of organoid production (1BR1and 2H9), the number of differentiation experiment performed to obtain 
enriched astrocytes was successfully achieved in three different times. Individual assays were performed three 
times, in triplicate, with different pool of cells, before and after freezing.
Murine embryonic fibroblast (MEF) cultures. Pregnant Swiss females at 2 gestational days were killed 
by exposure to halothane followed by cervical dislocation, and the embryos (E12) were removed. Head and red 
organs were dissected and washed in PBS, and all embryos were placed in a clean Petri dish. The embryos were 
incubated with trypsin (Sigma) for 15 min at 37 °C in a humidified 5% CO2, 95% air chamber. After incubation, 
the embryos were dissociated into single cells, and trypsin was inhibited by addition of DMEM-F12 (Invitrogen) 
supplemented with 10% FBS (Invitrogen). The sample was centrifuged at 200 g for 5 min, the supernatant was 
carefully removed and the cell pellet was suspended in warm MEF medium consisting of Dulbecco’s Modified 
Eagle’s Medium supplemented with the nutrient mixture F-12 (DMEM/F-12, Invitrogen) enriched with glucose 
(3.3 × 10−2 M), glutamine (2 × 10−3 M) and sodium bicarbonate (0.3 × 10−2 M) and supplemented with 10% FBS 
(Invitrogen) and 1% of penicillin-streptomycin (Invitrogen). Approximately 5 × 105 cells were plated into 0.2% 
gelatine-coated flasks (gelatine from bovine skin, Type B, Sigma) for 2 h and incubated at 37 °C in a humidified 5% 
CO2, 95% air chamber in DMEM/F-12 supplemented with 10% FBS medium for 2 h. After a secondary passage, 
the cells were plated on glass coverslips that had been previously coated with polyornithine (1.5 μ g/mL; Sigma). 
The cultures were then incubated under the same conditions until reaching confluency, and the medium was 
changed every 2 days.
Astrocyte conditioned medium preparation. After reaching confluency, the astrocyte monolayers were 
washed three times with PBS and incubated for two days in neurobasal medium (Invitrogen). After this period, 
BR1 and H9 astrocyte conditioned media were recovered, centrifuged at 1500 × g for 10 min, and used immedi-
ately or stored at − 70 °C for further use.
Neuronal-astrocyte conditioned medium assay. Pregnant Swiss females at 14 gestational days were 
killed by exposure to halothane followed by cervical dislocation, and the embryos (E14) were removed. Cortical 
progenitors were prepared as previously described29. Briefly, the cells were freshly dissociated from the cerebral 
cortex, and 10 × 104 cells were plated onto glass coverslips that had been previously coated with polyornithine 
(1.5 μ g/mL; Sigma) and grown in BR1 and H9 astrocyte conditioned medium or neurobasal medium (Invitrogen) 
for approximately 48 hours at 37 °C in a humidified 5% CO2, 95% air chamber.
Neuron-astrocyte coculture assay. Pregnant Swiss females at 14 gestational days were killed by exposure 
to halothane followed by cervical dislocation, and the embryos (E14) were removed. Cortical progenitors were 
prepared as previously described29. Briefly, for the coculture assays, the cells were freshly dissociated from cere-
bral cortex, and 5 × 104 cells were plated onto cell carpets from BR1-derived astrocytes, H9-derived astrocytes, 
MEFs derived from Swiss mice and murine astrocytes. The cocultures were maintained for 48 hours at 37 °C in a 
humidified 5% CO2, 95% air atmosphere.
Calcium signalling assay. Variations in free intracellular calcium levels [Ca2+]i were evaluated in single 
cells obtained from human astrocytes at stage 4 isolated from cerebral organoids. The astrocytes were grown as 
previously described on coated glass coverslips (15 mm) for 7–9 days to allow the formation of a monolayer. As 
controls, we used passage 1 murine neonatal cortical astrocytes that had been grown for 7–8 days. Astrocyte cul-
tures were loaded for 40 min with 5 μ M Fura-2/AM (Molecular Probes, Invitrogen Life Technologies, Carlsbad, 
California, USA) and 0.02% pluronic acid F-127 (Molecular Probes) in Krebs solution (132 mM NaCl, 4 mM 
KCl, 1.4 mM MgCl2, 2.5 mM CaCl2, 6 mM glucose, 10 mM HEPES, pH 7.4) and incubated at 37 °C in a humid-
ified 5% CO2, 95% air atmosphere. After the loading period, the cultures were washed three times with Krebs 
solution to remove the excess probes. The glass coverslip with the cell monolayer was mounted on an RC-20 
chamber in a PH3 platform (Warner Instruments, Hamden, CT) and visualized on an inverted fluorescence 
microscope (Axiovert 200; Carl Zeiss). Cells (approximately 100 cells per field) were continuously perfused with 
Krebs solution and stimulated with 100 μ M ATP (Sigma) solution (diluted in Krebs) for one minute. The solu-
tions were added to the cells via a fast-pressurized (95% air, 5% CO2 atmosphere) system (AutoMate Scientific, 
Inc., Berkeley, CA). The variations in [Ca2+]i were evaluated by quantifying the ratio of the fluorescence emitted 
at 510 nm following alternate excitation (750 ms) at 340 and 380 nm using a Lambda DG4 apparatus (Sutter 
Instrument, Novato, CA) and a 510-nm long-pass filter (Carl Zeiss) before fluorescence acquisition with a 409 
objective and a CoolSNAP digital camera (Roper Scientific, Trenton, NJ). Acquired values were processed using 
the MetaFluor software (Universal Imaging Corp., West Chester, PA). Values for the Fura-2 fluorescence ratio 
were calculated based on a cut-off of a 20% increase in the [Ca2+] level induced by the stimulus, resulting in the 
selection of 3 high values after stimulating each cell. At the cell baseline, we chose 10 prior values before ATP 
injection.
Immunohistochemistry of cerebral organoids. Cerebral organoids were fixed in 4% paraformalde-
hyde and incubated with sucrose gradient solutions (10, 20 and 30% in PBS) for 15 min each. They were then 
embedded in optimal cutting temperature compound (OCT) and frozen in liquid nitrogen. Twenty-micron-thick 
sections were permeabilized with 0.3% Triton-X (Vetec Química Fina Ltda, Rio de Janeiro, Rio de Janeiro, BR) 
for 5 min at room temperature. Subsequently, the tissue sections were blocked with 3% bovine serum albumin 
(BSA, Sigma) and 5% normal goat serum (NGS, Invitrogen) in PBS (block solution) for 1 h and incubated over-
night at 4 °C with the specified primary antibody diluted in blocking solution. The primary antibodies used were 
mouse anti-Nestin (1:200; Merck), rabbit anti-BLBP (1:200; Millipore), and rabbit anti-FOXG1 (1:00; Santa Cruz 
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Biotechnology, Inc.). Secondary antibodies were Alexa Fluor 546 goat anti-mouse (1:1,000; Molecular Probes) 
and Alexa Fluor 488 goat anti-rabbit (1:400; Molecular Probes). Negative controls were obtained by omitting the 
primary antibodies; in all cases, no reactivity was observed. DAPI (4′ ,6-diamidino-2-phenylindole, 1 mg/mL, 
Sigma) was used to stain nuclei. Images were acquired using an Operetta Imaging System (Perkin Elmer Inc.).
Immunocytochemistry of astrocytes. Cells were fixed with 4% paraformaldehyde for 15 min and per-
meabilized with 0.2% Triton-X (Vetec Química Fina Ltda) for 5 min at room temperature. Subsequently, the 
cells were blocked with 3% BSA (Sigma) and 5% NGS (Invitrogen) in PBS (block solution) for 1 h and incubated 
overnight at 4 °C with the specified primary antibody diluted in block solution. The primary antibodies were 
mouse anti-β -tubulin III (1:1,000; Promega Corporation; Madison, Wisconsin, USA), rabbit anti-GFAP (1:500; 
Dako, Glostrup, DK), rabbit anti-BLBP (1:200; Millipore), mouse anti-glutamine synthetase (1:200; Millipore), 
rabbit anti-S100β (1:200; Dako), mouse anti-vimentin (1:100; ABCAM), rabbit anti-GLAST (1:200; ABCAM), 
rabbit anti-GLT1 (1:200; ABCAM), rabbit anti-NMDAr (1:500; ABCAM), mouse anti-Nestin (1:100; Millipore), 
rabbit anti-olig2 (1:200; ABCAM), rabbit anti-FOXG1 (1:200; ABCAM), mouse anti-Cx43 (1:100; Invitrogen), 
and rabbit anti-pCx43 (1:500; Sigma). After incubation with the primary antibody, the cells were washed exten-
sively with PBS and incubated with the following secondary antibodies diluted in block solution for 2 h: goat 
anti-mouse IgG conjugated to Alexa Fluor 546 and 488 (Molecular Probes; 1:1,000 and 1:400, respectively) or 
goat anti-rabbit IgG conjugated to Alexa Fluor 488 and 546 (Molecular Probes; 1:400 and 1:1,000, respectively). 
Cell nuclei were labelled with 4′ ,6-diamidino-2-phenylindole dihydrochloride (DAPI; Sigma), and cell prepara-
tions were mounted directly onto Dako faramount aqueous mounting medium (Dako). Negative controls were 
obtained by omitting primary antibodies; in all cases, no reactivity was observed. After immunostaining, cell 
cultures were visualized using a Leica SP5 confocal microscope or TE300 Nikon microscope.
Liquid chromatography-mass spectrometry. Qualitative and quantitative proteomic analyses were 
performed in a bidimensional micro UPLC tandem nanoESI-HDMSE platform by multiplexed data-independent 
acquisition (DIA) experiments82. The Acquity UPLC M-Class System (Waters Corporation, Milford, MA) cou-
pled to a Synapt G2-Si mass spectrometer (Waters Corporation) was used.
Peptide loads were separated in a nanoACQUITY UPLC HSS T3 Column (1.8 μ m, 75 μ m X 150 mm, Waters 
Corporation). Peptides were eluted using an acetonitrile gradient ranging from 7% to 40% (v/v) for 95 min at a 
flow rate of 0.4 μ L/min directly into a Synapt G2-Si. For every measurement, the mass spectrometer was oper-
ated in resolution mode with an m/z resolving power of approximately 40 000 FWHM and using ion mobility 
with a cross-section resolving power at least 40 Ω/Δ Ω. The effective resolution obtained with the conjoined ion 
mobility was 1 800 000 FWHM. MS/MS analyses were performed by nanoelectrospray ionization in positive ion 
mode nanoESI (+) and with a NanoLock Spray (Waters Corporation, Manchester, UK) ionization source. The 
lock mass channel was sampled every 30 sec. The mass spectrometer was calibrated with an MS/MS spectrum 
of [Glu1]-Fibrinopeptide B human (Glu-Fib) solution that was delivered through the reference sprayer of the 
NanoLock Spray source.
Data processing analysis, database search and quantification. For spectra processing and database 
search we used Progenesis QI for Proteomics software package with Apex3D, peptide 3D, and ion accounting 
informatics (Waters Corporation). The software loads LC-MS data, followed by chromatogram alignment and 
peak detection. A list of curated ions (peptides) are explored within Peptide Ion Stats by multivariate statistical 
methods; next, relative intensities for all ions are normalized among runs through total ion current. Finally, pep-
tides are searched against a human proteome database (UniProt Human Reference Proteome, version 2015/11; 
70,225 entries) for protein identification employing default parameters for ion accounting and quantitation 4. 
Protin database was reversed “on the fly” during the database queries and appended to the original database to 
assess the false-positive identification rate. The following parameters were considered for identifying peptides: 1) 
Digestion by trypsin with one missed cleavage allowed; 2) Methionine oxidation as variable modifications and 
carbamidomethyl (C) as fixed modification; 3) false discovery rate (FDR) lower than 1%. The protein identified 
with the highest score is chosen automatically as reference. Its intensity is used as a normalization factor for the 
relative quantification of all other proteins across the conditions analyzed (normalized abundance).
Pathway and functional protein analysis. Proteins were analysed using the functional annotation anal-
ysis tool Panther (http://pantherdb.org/)83 to identify over-represented ontological groups and pathways amongst 
BR1 and H9 astrocyte and human adult astrocyte proteins. Using the abundant proteins found in those pathways, 
we explored the protein-protein interactome as an interactive representation showing the molecular relationship 
between molecules from the dataset based on STRING interactions with high confidence (www.string-db.org) - 
Search Tool for the Retrieval of Interacting Genes/Proteins84. The parameters used were (i) a minimum required 
interaction score: height confidence 0.7 and (ii) active interaction sources: textming, experiments, database, 
co-expression, neighbourhood, gene fusion and co-occurrence.
Neuronal morphometry. To analyse neurite outgrowth, neuronal cells cultured either on BR1 or H9 astro-
cyte conditioned medium or neurobasal medium (Invitrogen) were measured using the NeuronJ plug-in in the 
ImageJ 1.36b software. At least ten fields were measured per well. In all cases, at least 100 neurons randomly 
chosen were observed per well. All neurites that emerged from neuronal soma were considered. Neurite length 
was analysed using 3 different methods either considering only the major process per neuron, the sum of all 
neurite measurements per neuron and the sum of all neurite measurements divided by the number of processes 
per neuron7.
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Statistical Analysis. Astrocytes were isolated from cerebral organoids derived from different series of 
organoid production (1-BR1and 2-H9), the number of differentiation experiment performed to obtain enriched 
astrocytes was successfully achieved in three different times (N=3). The individual assays with passage 4 astro-
cytes were performed three times, in triplicate, with different pool of cells, before and after freezing. Statistical 
analyses were performed using one-way nonparametric ANOVA coupled to Tukey’s post-test using GraphPad 
Prism 4.0 software, and P < 0.05 was considered statistically significant.
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